Clinical Trials Directory

Trials / Completed

CompletedNCT04748263

Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Centre Hospitalier Princesse Grace · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers

Summary

It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior disorders. This kind of disorders are observed in Fronto-Temporal Dementia (FTD), Alzheimer's Dementia (AD) and Parkinson's Disease (PD), with severe deficits in FTD and lighter deficits in AD and PD. One explanation might be that patients apply inappropriate visual exploration strategies to decode emotions and intentions of others. This study aims to test this hypothesis and further to analyse whether different patterns emerge from these pathologies.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention. Only survey and normal use of eye-trackingThe study is conducted in accordance with usual practices of eye-tracking and neuropsychological evaluations carried out at the Center Rainier III. Eye-Tracker® is used at the Centre Rainier III since August 2014. It is a non-invasive device for eye movements recording, allowing doctors and researchers to measure standard parameters related to eye movements. Developed by the Eye Brain Company (France), this is a Class IIa medical device, CE marking, according to Annexe IX of the directive 93/42/CE.

Timeline

Start date
2015-07-01
Primary completion
2019-12-01
Completion
2020-11-01
First posted
2021-02-10
Last updated
2021-02-10

Source: ClinicalTrials.gov record NCT04748263. Inclusion in this directory is not an endorsement.